Predict your next investment

Other

See what CB Insights has to offer

Investments

1

About Ruomu Capital

Ruomu Capital (若沐资本) is based in China.

Ruomu Capital Headquarter Location

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Ruomu Capital News

NuProbe Raises $42M in Funding

Jan 11, 2021

NuProbe , a Houston, USA, Shanghai, China and Suzhou, China-based genomics and molecular diagnostics company specialized in ultrasensitive sequencing panels, closed a $42M funding round. The round was led by BioTrack Capital and Yonghua Capital with participation from Taifu Capital, Panlin Capital, Juming Capital, and Tuobang Capital and previous investors Sequoia Capital China, Ruomu Capital, and Serica Partners. The company intends to use the funds to expand the commercial team in both the US and China, develop new NGS products, and file for regulatory approval in China for NuProbe’s clinical products. Led by Yingshuang Chai, co-founder and CEO, NuProbe is a genomics and molecular diagnostics company with molecular diagnostic technologies to improve the sensitivity of sequencing mutations and copy number variations by over 10-fold. In the past 12 months, NuProbe has signed a number of partnership and licensing deals with internationally renowned companies in molecular diagnostics and life sciences, including Illumina, Qiagen, Oxford Nanopore, and the Wego Group. The company has begun to partner with pharma companies for clinical research through its Augury™ custom NGS panels. In the reproductive health field in China, NuProbe has built collaborations with most of the top hospitals and is the leader in infertility testing. The team also includes David Zhang, co-founder and Head of Innovation while the scientific advisory board includes David Walt and George Church. FinSMEs 11/01/2020

Ruomu Capital Investments

1 Investments

Ruomu Capital has made 1 investments. Their latest investment was in Meishubao as part of their Series B - II on September 9, 2016.

CBI Logo

Ruomu Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/1/2016

Series B - II

Meishubao

$7.79M

Yes

2

Date

9/1/2016

Round

Series B - II

Company

Meishubao

Amount

$7.79M

New?

Yes

Co-Investors

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.